| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 82 | 2020 | 476 | 28.020 |
Why?
|
| Tissue Engineering | 203 | 2024 | 659 | 25.900 |
Why?
|
| Regenerative Medicine | 65 | 2024 | 202 | 14.910 |
Why?
|
| Urinary Bladder Neoplasms | 35 | 2020 | 192 | 14.010 |
Why?
|
| Tissue Scaffolds | 101 | 2023 | 421 | 11.560 |
Why?
|
| Animals | 371 | 2024 | 7569 | 11.170 |
Why?
|
| Humans | 543 | 2024 | 32799 | 10.370 |
Why?
|
| Stem Cells | 86 | 2024 | 314 | 9.900 |
Why?
|
| Stem Cell Transplantation | 61 | 2021 | 212 | 9.250 |
Why?
|
| Receptors, Androgen | 22 | 2020 | 43 | 8.210 |
Why?
|
| Urinary Bladder | 44 | 2019 | 183 | 7.870 |
Why?
|
| Biocompatible Materials | 73 | 2024 | 233 | 7.640 |
Why?
|
| Urethra | 34 | 2017 | 100 | 6.970 |
Why?
|
| Male | 252 | 2022 | 19642 | 6.840 |
Why?
|
| Kidney Neoplasms | 19 | 2019 | 205 | 6.170 |
Why?
|
| Regeneration | 42 | 2023 | 170 | 5.970 |
Why?
|
| Carcinoma, Renal Cell | 16 | 2019 | 116 | 5.900 |
Why?
|
| MicroRNAs | 17 | 2020 | 188 | 5.720 |
Why?
|
| Cell Differentiation | 71 | 2023 | 467 | 5.590 |
Why?
|
| Organoids | 23 | 2024 | 98 | 5.450 |
Why?
|
| Cell Culture Techniques | 39 | 2020 | 172 | 4.880 |
Why?
|
| Kidney | 39 | 2021 | 520 | 4.790 |
Why?
|
| Hydrogels | 33 | 2023 | 126 | 4.510 |
Why?
|
| Mesenchymal Stem Cells | 28 | 2023 | 182 | 4.510 |
Why?
|
| Prostate | 11 | 2017 | 69 | 4.500 |
Why?
|
| Extracellular Matrix | 45 | 2020 | 243 | 4.380 |
Why?
|
| Carcinoma, Transitional Cell | 10 | 2020 | 70 | 4.330 |
Why?
|
| Signal Transduction | 21 | 2020 | 686 | 4.150 |
Why?
|
| Escherichia coli Infections | 7 | 2019 | 39 | 4.020 |
Why?
|
| Fertility | 10 | 2020 | 23 | 3.780 |
Why?
|
| Urothelium | 18 | 2020 | 55 | 3.700 |
Why?
|
| Collagen | 37 | 2022 | 219 | 3.590 |
Why?
|
| Cell Transplantation | 21 | 2017 | 64 | 3.440 |
Why?
|
| Amniotic Fluid | 33 | 2019 | 86 | 3.440 |
Why?
|
| Cells, Cultured | 77 | 2023 | 820 | 3.330 |
Why?
|
| Cell Proliferation | 54 | 2021 | 602 | 3.060 |
Why?
|
| Penis | 12 | 2019 | 35 | 3.060 |
Why?
|
| Mice | 87 | 2023 | 2511 | 3.040 |
Why?
|
| Epithelial Cells | 14 | 2023 | 129 | 3.010 |
Why?
|
| Urology | 9 | 2024 | 31 | 3.010 |
Why?
|
| Adult Stem Cells | 8 | 2020 | 25 | 2.820 |
Why?
|
| Wound Healing | 18 | 2023 | 188 | 2.820 |
Why?
|
| Erectile Dysfunction | 9 | 2020 | 50 | 2.730 |
Why?
|
| Urinary Tract Infections | 6 | 2019 | 46 | 2.710 |
Why?
|
| Spermatogenesis | 10 | 2022 | 47 | 2.710 |
Why?
|
| Spermatozoa | 8 | 2020 | 28 | 2.680 |
Why?
|
| Transcription Factors | 11 | 2023 | 176 | 2.620 |
Why?
|
| Urinary Bladder, Neurogenic | 8 | 2014 | 18 | 2.480 |
Why?
|
| Reconstructive Surgical Procedures | 19 | 2019 | 198 | 2.440 |
Why?
|
| Uropathogenic Escherichia coli | 5 | 2019 | 6 | 2.390 |
Why?
|
| Neoplasms | 14 | 2019 | 761 | 2.380 |
Why?
|
| Embryonic Stem Cells | 11 | 2015 | 28 | 2.350 |
Why?
|
| Myocytes, Smooth Muscle | 19 | 2017 | 72 | 2.240 |
Why?
|
| Urethral Stricture | 10 | 2015 | 31 | 2.230 |
Why?
|
| Female | 111 | 2023 | 20262 | 2.220 |
Why?
|
| Neovascularization, Physiologic | 20 | 2021 | 111 | 2.200 |
Why?
|
| Escherichia coli | 7 | 2019 | 83 | 2.120 |
Why?
|
| Rats | 58 | 2020 | 1606 | 2.100 |
Why?
|
| Pluripotent Stem Cells | 8 | 2020 | 18 | 2.080 |
Why?
|
| Skin | 11 | 2023 | 214 | 2.070 |
Why?
|
| Apoptosis | 10 | 2021 | 362 | 2.000 |
Why?
|
| Endothelial Cells | 24 | 2022 | 197 | 1.990 |
Why?
|
| Testis | 13 | 2022 | 65 | 1.950 |
Why?
|
| Neoplastic Stem Cells | 7 | 2019 | 98 | 1.930 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2020 | 264 | 1.900 |
Why?
|
| Organ Transplantation | 8 | 2019 | 66 | 1.880 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2019 | 107 | 1.880 |
Why?
|
| Osteogenesis | 15 | 2022 | 81 | 1.880 |
Why?
|
| Cell Line, Tumor | 21 | 2024 | 726 | 1.870 |
Why?
|
| Urologic Neoplasms | 3 | 2020 | 14 | 1.860 |
Why?
|
| Disease Models, Animal | 28 | 2022 | 1012 | 1.840 |
Why?
|
| Neurons | 6 | 2020 | 416 | 1.830 |
Why?
|
| Endothelium, Vascular | 11 | 2020 | 155 | 1.820 |
Why?
|
| Placenta | 9 | 2023 | 75 | 1.810 |
Why?
|
| Artificial Organs | 6 | 2020 | 13 | 1.770 |
Why?
|
| Cell Movement | 15 | 2019 | 171 | 1.760 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 5 | 2020 | 10 | 1.760 |
Why?
|
| Transcription, Genetic | 5 | 2019 | 134 | 1.750 |
Why?
|
| Wounds and Injuries | 7 | 2019 | 245 | 1.740 |
Why?
|
| Cell Survival | 35 | 2020 | 280 | 1.740 |
Why?
|
| Muscle Fibers, Skeletal | 15 | 2020 | 107 | 1.710 |
Why?
|
| Blood-Brain Barrier | 4 | 2024 | 50 | 1.690 |
Why?
|
| Androgen Antagonists | 4 | 2019 | 19 | 1.690 |
Why?
|
| Antineoplastic Agents | 6 | 2016 | 599 | 1.670 |
Why?
|
| Urinary Bladder Diseases | 6 | 2020 | 20 | 1.660 |
Why?
|
| Bioreactors | 13 | 2018 | 61 | 1.650 |
Why?
|
| Transforming Growth Factor beta | 6 | 2019 | 60 | 1.610 |
Why?
|
| Urinary Tract | 5 | 2019 | 22 | 1.600 |
Why?
|
| Urinary Incontinence, Stress | 10 | 2017 | 66 | 1.590 |
Why?
|
| Liver | 18 | 2020 | 492 | 1.590 |
Why?
|
| Urologic Surgical Procedures, Male | 8 | 2019 | 17 | 1.550 |
Why?
|
| Rabbits | 30 | 2023 | 192 | 1.550 |
Why?
|
| Urologic Surgical Procedures | 7 | 2015 | 64 | 1.540 |
Why?
|
| Myoblasts | 10 | 2017 | 37 | 1.510 |
Why?
|
| Muscle, Skeletal | 22 | 2020 | 524 | 1.500 |
Why?
|
| Phenotype | 14 | 2023 | 638 | 1.490 |
Why?
|
| Bioengineering | 11 | 2016 | 68 | 1.490 |
Why?
|
| Cartilage | 8 | 2019 | 31 | 1.470 |
Why?
|
| Inflammation | 8 | 2020 | 536 | 1.460 |
Why?
|
| Reproduction | 5 | 2020 | 14 | 1.450 |
Why?
|
| Amnion | 5 | 2019 | 37 | 1.440 |
Why?
|
| Telomerase | 5 | 2016 | 20 | 1.440 |
Why?
|
| Reperfusion Injury | 5 | 2020 | 57 | 1.440 |
Why?
|
| Infertility, Male | 5 | 2016 | 24 | 1.430 |
Why?
|
| Pharmaceutical Preparations | 4 | 2021 | 37 | 1.430 |
Why?
|
| Muscle, Smooth | 15 | 2022 | 69 | 1.420 |
Why?
|
| Phosphoproteins | 3 | 2015 | 48 | 1.410 |
Why?
|
| Urogenital System | 7 | 2006 | 9 | 1.400 |
Why?
|
| Cloning, Organism | 8 | 2009 | 12 | 1.370 |
Why?
|
| Genomics | 5 | 2018 | 88 | 1.370 |
Why?
|
| Testosterone | 7 | 2022 | 48 | 1.350 |
Why?
|
| Vascular Endothelial Growth Factor A | 16 | 2022 | 117 | 1.340 |
Why?
|
| Sperm Motility | 3 | 2016 | 8 | 1.330 |
Why?
|
| Kidney Calculi | 3 | 2020 | 23 | 1.310 |
Why?
|
| Lab-On-A-Chip Devices | 6 | 2023 | 29 | 1.290 |
Why?
|
| Polymers | 13 | 2016 | 66 | 1.280 |
Why?
|
| Asthenozoospermia | 3 | 2014 | 3 | 1.270 |
Why?
|
| Postural Balance | 3 | 2016 | 180 | 1.260 |
Why?
|
| Gold | 4 | 2024 | 19 | 1.250 |
Why?
|
| Cryopreservation | 7 | 2021 | 57 | 1.240 |
Why?
|
| Genes, Tumor Suppressor | 5 | 2017 | 34 | 1.230 |
Why?
|
| Urine | 11 | 2018 | 65 | 1.220 |
Why?
|
| Urologic Diseases | 6 | 2009 | 27 | 1.220 |
Why?
|
| Pesticides | 3 | 2016 | 196 | 1.220 |
Why?
|
| Nanoparticles | 4 | 2019 | 56 | 1.210 |
Why?
|
| Bioprosthesis | 7 | 2017 | 61 | 1.200 |
Why?
|
| Occupational Exposure | 3 | 2016 | 231 | 1.200 |
Why?
|
| DNA Methylation | 3 | 2020 | 144 | 1.190 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2016 | 154 | 1.180 |
Why?
|
| Pregnancy | 25 | 2023 | 981 | 1.180 |
Why?
|
| Metal Nanoparticles | 3 | 2024 | 17 | 1.180 |
Why?
|
| Emigrants and Immigrants | 3 | 2016 | 240 | 1.170 |
Why?
|
| Swine | 25 | 2023 | 216 | 1.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2019 | 44 | 1.160 |
Why?
|
| Estrogen Receptor beta | 3 | 2019 | 12 | 1.150 |
Why?
|
| Transients and Migrants | 3 | 2016 | 298 | 1.150 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2015 | 18 | 1.150 |
Why?
|
| Spheroids, Cellular | 7 | 2021 | 38 | 1.140 |
Why?
|
| Recovery of Function | 10 | 2020 | 203 | 1.140 |
Why?
|
| Fetal Blood | 3 | 2017 | 38 | 1.130 |
Why?
|
| Guided Tissue Regeneration | 11 | 2020 | 38 | 1.120 |
Why?
|
| Bone Neoplasms | 4 | 2022 | 116 | 1.120 |
Why?
|
| Blood Vessel Prosthesis | 9 | 2017 | 84 | 1.120 |
Why?
|
| Periodicals as Topic | 5 | 2018 | 91 | 1.110 |
Why?
|
| Muscle Development | 12 | 2020 | 49 | 1.110 |
Why?
|
| Cisplatin | 5 | 2020 | 81 | 1.110 |
Why?
|
| Receptor, erbB-2 | 2 | 2019 | 65 | 1.110 |
Why?
|
| Infertility | 2 | 2020 | 14 | 1.100 |
Why?
|
| Cell Separation | 15 | 2019 | 90 | 1.100 |
Why?
|
| Kidney Diseases | 5 | 2018 | 250 | 1.100 |
Why?
|
| Disease Progression | 8 | 2020 | 594 | 1.090 |
Why?
|
| Skin, Artificial | 4 | 2024 | 33 | 1.090 |
Why?
|
| Muscle Contraction | 8 | 2014 | 113 | 1.090 |
Why?
|
| Blood Vessels | 7 | 2019 | 51 | 1.080 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 33 | 1.080 |
Why?
|
| Bioartificial Organs | 10 | 2014 | 25 | 1.070 |
Why?
|
| Myocardium | 8 | 2020 | 191 | 1.070 |
Why?
|
| Androgens | 5 | 2020 | 28 | 1.070 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 8 | 2019 | 82 | 1.060 |
Why?
|
| Lung | 8 | 2023 | 265 | 1.050 |
Why?
|
| Materials Testing | 18 | 2020 | 92 | 1.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2019 | 10 | 1.040 |
Why?
|
| Models, Biological | 7 | 2020 | 392 | 1.040 |
Why?
|
| Neoplasm Proteins | 4 | 2016 | 145 | 1.020 |
Why?
|
| Vagina | 5 | 2014 | 59 | 1.020 |
Why?
|
| Ciprofloxacin | 2 | 2017 | 12 | 1.020 |
Why?
|
| Myocytes, Cardiac | 6 | 2018 | 94 | 1.020 |
Why?
|
| Intestinal Mucosa | 5 | 2021 | 73 | 1.010 |
Why?
|
| Cystitis, Interstitial | 2 | 2020 | 53 | 1.000 |
Why?
|
| Chondrocytes | 8 | 2015 | 69 | 1.000 |
Why?
|
| Biomedical Research | 4 | 2024 | 171 | 0.990 |
Why?
|
| Nerve Regeneration | 9 | 2020 | 49 | 0.990 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2017 | 59 | 0.990 |
Why?
|
| Mice, Nude | 27 | 2020 | 290 | 0.980 |
Why?
|
| Peptide Elongation Factors | 2 | 2016 | 2 | 0.980 |
Why?
|
| Graft Rejection | 2 | 2019 | 241 | 0.970 |
Why?
|
| Polyesters | 16 | 2020 | 78 | 0.960 |
Why?
|
| Ureter | 6 | 2020 | 38 | 0.950 |
Why?
|
| Tissue Transplantation | 5 | 2019 | 15 | 0.950 |
Why?
|
| Hispanic Americans | 3 | 2016 | 930 | 0.940 |
Why?
|
| RNA, Small Interfering | 3 | 2017 | 113 | 0.940 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 26 | 0.940 |
Why?
|
| Transfection | 8 | 2019 | 184 | 0.940 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2015 | 25 | 0.930 |
Why?
|
| Telomere | 3 | 2016 | 11 | 0.930 |
Why?
|
| Longevity | 2 | 2020 | 21 | 0.920 |
Why?
|
| Klinefelter Syndrome | 5 | 2022 | 8 | 0.920 |
Why?
|
| Gene Expression Profiling | 9 | 2016 | 316 | 0.920 |
Why?
|
| Carcinogens | 2 | 2016 | 35 | 0.920 |
Why?
|
| Genitalia | 3 | 2014 | 8 | 0.910 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2019 | 78 | 0.910 |
Why?
|
| Kidney Transplantation | 6 | 2017 | 512 | 0.910 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2016 | 34 | 0.880 |
Why?
|
| Cadherins | 2 | 2015 | 27 | 0.880 |
Why?
|
| Urination | 3 | 2014 | 16 | 0.880 |
Why?
|
| Sex Differentiation | 2 | 2015 | 5 | 0.880 |
Why?
|
| Biosensing Techniques | 3 | 2019 | 25 | 0.880 |
Why?
|
| RNA, Messenger | 9 | 2022 | 498 | 0.880 |
Why?
|
| Epididymis | 2 | 2015 | 9 | 0.870 |
Why?
|
| Lipogenesis | 3 | 2019 | 18 | 0.870 |
Why?
|
| Cytokines | 8 | 2021 | 247 | 0.870 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 67 | 0.870 |
Why?
|
| Spermatogonia | 5 | 2022 | 14 | 0.870 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 154 | 0.860 |
Why?
|
| Hypospadias | 7 | 2012 | 10 | 0.860 |
Why?
|
| Research | 2 | 2020 | 76 | 0.860 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2020 | 297 | 0.860 |
Why?
|
| Rats, Sprague-Dawley | 18 | 2021 | 754 | 0.850 |
Why?
|
| Myeloid Cells | 2 | 2015 | 39 | 0.850 |
Why?
|
| Urinary Bladder, Overactive | 2 | 2014 | 16 | 0.850 |
Why?
|
| Dogs | 11 | 2015 | 120 | 0.840 |
Why?
|
| Prostatic Hyperplasia | 3 | 2013 | 44 | 0.840 |
Why?
|
| Penile Prosthesis | 8 | 2009 | 19 | 0.830 |
Why?
|
| Doxorubicin | 1 | 2024 | 83 | 0.830 |
Why?
|
| Cartilage, Articular | 3 | 2023 | 75 | 0.820 |
Why?
|
| Pyrroles | 2 | 2014 | 52 | 0.820 |
Why?
|
| Myoblasts, Skeletal | 5 | 2020 | 19 | 0.820 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2013 | 8 | 0.820 |
Why?
|
| Nuclear Proteins | 3 | 2019 | 76 | 0.820 |
Why?
|
| Epigenesis, Genetic | 4 | 2020 | 107 | 0.810 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2017 | 64 | 0.800 |
Why?
|
| Organ Culture Techniques | 6 | 2016 | 39 | 0.790 |
Why?
|
| Transcriptional Activation | 3 | 2014 | 41 | 0.790 |
Why?
|
| NF-kappa B | 2 | 2020 | 83 | 0.790 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 71 | 0.790 |
Why?
|
| Cystoscopy | 4 | 2014 | 27 | 0.790 |
Why?
|
| Hyaluronic Acid | 8 | 2022 | 54 | 0.770 |
Why?
|
| Printing | 2 | 2012 | 5 | 0.770 |
Why?
|
| Heart Valve Prosthesis | 5 | 2015 | 60 | 0.770 |
Why?
|
| Hemophilia A | 4 | 2023 | 26 | 0.770 |
Why?
|
| Gene Transfer Techniques | 9 | 2022 | 65 | 0.770 |
Why?
|
| Urethral Diseases | 4 | 2014 | 17 | 0.760 |
Why?
|
| Glioblastoma | 1 | 2024 | 157 | 0.760 |
Why?
|
| DNA, Mitochondrial | 4 | 2020 | 34 | 0.760 |
Why?
|
| Osteoarthritis, Knee | 1 | 2023 | 81 | 0.760 |
Why?
|
| Uterus | 4 | 2023 | 79 | 0.750 |
Why?
|
| Drug Discovery | 3 | 2023 | 36 | 0.750 |
Why?
|
| Mutation | 7 | 2020 | 493 | 0.750 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2021 | 28 | 0.750 |
Why?
|
| RNA | 4 | 2019 | 87 | 0.750 |
Why?
|
| Polyglycolic Acid | 9 | 2023 | 33 | 0.750 |
Why?
|
| Genetic Vectors | 8 | 2022 | 120 | 0.750 |
Why?
|
| Spinal Cord Injuries | 2 | 2014 | 40 | 0.740 |
Why?
|
| Receptor, Notch1 | 3 | 2017 | 6 | 0.740 |
Why?
|
| Adult | 37 | 2024 | 9561 | 0.740 |
Why?
|
| Intestinal Obstruction | 1 | 2022 | 12 | 0.740 |
Why?
|
| Plasmids | 5 | 2019 | 45 | 0.730 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 300 | 0.730 |
Why?
|
| Genome-Wide Association Study | 3 | 2020 | 549 | 0.720 |
Why?
|
| Cell Count | 5 | 2017 | 48 | 0.720 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2017 | 12 | 0.720 |
Why?
|
| Live Birth | 2 | 2023 | 5 | 0.710 |
Why?
|
| Penile Erection | 3 | 2020 | 21 | 0.710 |
Why?
|
| Biomedical Engineering | 8 | 2015 | 26 | 0.710 |
Why?
|
| PPAR gamma | 2 | 2019 | 44 | 0.710 |
Why?
|
| Breast Neoplasms | 4 | 2016 | 754 | 0.710 |
Why?
|
| Hepatocytes | 7 | 2023 | 82 | 0.700 |
Why?
|
| Female Urogenital Diseases | 3 | 2006 | 4 | 0.700 |
Why?
|
| Male Urogenital Diseases | 3 | 2006 | 4 | 0.700 |
Why?
|
| Bladder Exstrophy | 6 | 2007 | 8 | 0.690 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 428 | 0.690 |
Why?
|
| Cystic Fibrosis | 3 | 2019 | 23 | 0.690 |
Why?
|
| Immunohistochemistry | 21 | 2017 | 497 | 0.690 |
Why?
|
| Paneth Cells | 1 | 2021 | 4 | 0.690 |
Why?
|
| Child | 22 | 2022 | 2478 | 0.690 |
Why?
|
| Adhesins, Escherichia coli | 2 | 2017 | 3 | 0.680 |
Why?
|
| Oocytes | 4 | 2016 | 46 | 0.680 |
Why?
|
| Ileum | 1 | 2021 | 16 | 0.680 |
Why?
|
| Cell Line | 14 | 2019 | 433 | 0.680 |
Why?
|
| Stress, Mechanical | 8 | 2016 | 96 | 0.680 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 9 | 2020 | 98 | 0.670 |
Why?
|
| Sertoli Cells | 2 | 2022 | 6 | 0.670 |
Why?
|
| Succinic Acid | 1 | 2020 | 2 | 0.670 |
Why?
|
| Fimbriae, Bacterial | 2 | 2017 | 2 | 0.660 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 37 | 0.660 |
Why?
|
| Tissue Array Analysis | 2 | 2017 | 36 | 0.650 |
Why?
|
| Oxidative Stress | 3 | 2020 | 239 | 0.650 |
Why?
|
| Transplantation, Autologous | 12 | 2020 | 84 | 0.650 |
Why?
|
| Fibroblasts | 9 | 2021 | 114 | 0.650 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2015 | 24 | 0.640 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 129 | 0.640 |
Why?
|
| Blood Banks | 2 | 2017 | 7 | 0.640 |
Why?
|
| Up-Regulation | 5 | 2018 | 191 | 0.630 |
Why?
|
| Iliac Artery | 1 | 2020 | 48 | 0.630 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2019 | 10 | 0.630 |
Why?
|
| Microscopy, Electron, Scanning | 19 | 2020 | 94 | 0.630 |
Why?
|
| Antigens, CD | 4 | 2018 | 101 | 0.620 |
Why?
|
| Acinetobacter baumannii | 1 | 2019 | 6 | 0.620 |
Why?
|
| Drug Monitoring | 1 | 2019 | 28 | 0.620 |
Why?
|
| Quorum Sensing | 1 | 2019 | 2 | 0.610 |
Why?
|
| Sirtuin 3 | 1 | 2019 | 3 | 0.610 |
Why?
|
| Oxidoreductases | 1 | 2019 | 25 | 0.610 |
Why?
|
| Lactic Acid | 6 | 2014 | 58 | 0.610 |
Why?
|
| DNA Mismatch Repair | 1 | 2019 | 8 | 0.610 |
Why?
|
| Chondrogenesis | 3 | 2015 | 20 | 0.610 |
Why?
|
| Cell Lineage | 8 | 2018 | 71 | 0.610 |
Why?
|
| Nuclear Pore | 1 | 2019 | 2 | 0.610 |
Why?
|
| Lysosomes | 1 | 2019 | 10 | 0.610 |
Why?
|
| Peptides | 4 | 2016 | 125 | 0.600 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2019 | 1 | 0.600 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2019 | 3 | 0.600 |
Why?
|
| Glycoproteins | 3 | 2015 | 36 | 0.600 |
Why?
|
| Adolescent | 20 | 2022 | 3638 | 0.600 |
Why?
|
| Amino Acids | 2 | 2019 | 46 | 0.600 |
Why?
|
| Drug Delivery Systems | 7 | 2020 | 105 | 0.600 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2020 | 947 | 0.600 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 13 | 0.600 |
Why?
|
| Postoperative Complications | 9 | 2022 | 828 | 0.600 |
Why?
|
| Protein-Serine-Threonine Kinases | 2 | 2019 | 49 | 0.590 |
Why?
|
| Trans-Activators | 3 | 2015 | 42 | 0.590 |
Why?
|
| DNA | 6 | 2022 | 218 | 0.590 |
Why?
|
| DNA-Binding Proteins | 4 | 2018 | 142 | 0.580 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 332 | 0.580 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 89 | 0.580 |
Why?
|
| Bone Marrow Transplantation | 2 | 2016 | 66 | 0.580 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 157 | 0.570 |
Why?
|
| Periplasmic Proteins | 1 | 2018 | 3 | 0.570 |
Why?
|
| Fibrosis | 6 | 2022 | 122 | 0.570 |
Why?
|
| Smoke | 1 | 2018 | 16 | 0.570 |
Why?
|
| Hemodynamics | 2 | 2017 | 162 | 0.570 |
Why?
|
| Membrane Proteins | 5 | 2015 | 251 | 0.570 |
Why?
|
| p21-Activated Kinases | 2 | 2020 | 5 | 0.570 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2018 | 1 | 0.570 |
Why?
|
| Escherichia coli Proteins | 1 | 2018 | 33 | 0.560 |
Why?
|
| Prostate-Specific Antigen | 4 | 2019 | 63 | 0.560 |
Why?
|
| Angiotensin II | 1 | 2019 | 245 | 0.560 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2018 | 10 | 0.560 |
Why?
|
| Repressor Proteins | 4 | 2019 | 50 | 0.560 |
Why?
|
| Nuclear Transfer Techniques | 5 | 2009 | 9 | 0.560 |
Why?
|
| Bacteriuria | 1 | 2018 | 4 | 0.560 |
Why?
|
| Sodium | 1 | 2018 | 40 | 0.550 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2015 | 36 | 0.550 |
Why?
|
| Patient Care | 1 | 2018 | 30 | 0.550 |
Why?
|
| Adipose Tissue | 3 | 2016 | 349 | 0.550 |
Why?
|
| Cyclooxygenase 2 | 3 | 2013 | 50 | 0.550 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 59 | 0.540 |
Why?
|
| Hydroxamic Acids | 2 | 2015 | 21 | 0.540 |
Why?
|
| Medicine | 2 | 2016 | 40 | 0.540 |
Why?
|
| Bone and Bones | 7 | 2019 | 94 | 0.540 |
Why?
|
| Anesthetics | 1 | 2017 | 19 | 0.540 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 194 | 0.540 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2017 | 7 | 0.540 |
Why?
|
| Vesico-Ureteral Reflux | 7 | 2013 | 20 | 0.540 |
Why?
|
| Ink | 2 | 2019 | 11 | 0.530 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2017 | 4 | 0.530 |
Why?
|
| Multipotent Stem Cells | 4 | 2013 | 17 | 0.530 |
Why?
|
| Catechin | 1 | 2017 | 5 | 0.530 |
Why?
|
| Prostatitis | 2 | 2015 | 3 | 0.530 |
Why?
|
| Sus scrofa | 8 | 2017 | 47 | 0.530 |
Why?
|
| Urease | 1 | 2017 | 1 | 0.520 |
Why?
|
| Proteus mirabilis | 1 | 2017 | 2 | 0.520 |
Why?
|
| Absorbable Implants | 2 | 2014 | 25 | 0.520 |
Why?
|
| Anesthesia | 1 | 2017 | 64 | 0.520 |
Why?
|
| Claudins | 1 | 2017 | 8 | 0.520 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2016 | 27 | 0.520 |
Why?
|
| Gelatin | 8 | 2022 | 29 | 0.520 |
Why?
|
| RNA Interference | 2 | 2016 | 77 | 0.520 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2017 | 8 | 0.520 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2017 | 9 | 0.520 |
Why?
|
| Cell Cycle | 2 | 2015 | 74 | 0.520 |
Why?
|
| Soybean Oil | 1 | 2017 | 9 | 0.520 |
Why?
|
| Myoglobin | 2 | 2016 | 11 | 0.520 |
Why?
|
| Biosynthetic Pathways | 1 | 2016 | 3 | 0.510 |
Why?
|
| Phospholipids | 1 | 2017 | 29 | 0.510 |
Why?
|
| Infant | 14 | 2020 | 1083 | 0.510 |
Why?
|
| Liver Cirrhosis | 2 | 2019 | 82 | 0.510 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2017 | 384 | 0.510 |
Why?
|
| Gallium | 1 | 2016 | 1 | 0.510 |
Why?
|
| Ovarian Follicle | 1 | 2016 | 29 | 0.500 |
Why?
|
| Child, Preschool | 13 | 2020 | 1282 | 0.500 |
Why?
|
| Porphyrins | 1 | 2016 | 29 | 0.500 |
Why?
|
| Bupivacaine | 1 | 2017 | 52 | 0.500 |
Why?
|
| beta Catenin | 2 | 2015 | 36 | 0.500 |
Why?
|
| Pulmonary Fibrosis | 1 | 2016 | 10 | 0.500 |
Why?
|
| Liver Transplantation | 5 | 2014 | 183 | 0.500 |
Why?
|
| Tubulin | 1 | 2016 | 11 | 0.500 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2016 | 11 | 0.500 |
Why?
|
| Stromal Cells | 3 | 2019 | 67 | 0.500 |
Why?
|
| Zinc | 2 | 2019 | 31 | 0.490 |
Why?
|
| Flavonoids | 1 | 2016 | 19 | 0.490 |
Why?
|
| Y Chromosome | 1 | 2016 | 43 | 0.490 |
Why?
|
| Formaldehyde | 1 | 2016 | 11 | 0.490 |
Why?
|
| Diterpenes | 1 | 2016 | 17 | 0.490 |
Why?
|
| Salivary Glands | 2 | 2007 | 14 | 0.490 |
Why?
|
| Protoporphyrins | 1 | 2016 | 16 | 0.490 |
Why?
|
| Sperm Capacitation | 1 | 2016 | 3 | 0.490 |
Why?
|
| Cancer Vaccines | 1 | 2016 | 24 | 0.480 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2015 | 2 | 0.480 |
Why?
|
| Podocytes | 2 | 2019 | 20 | 0.480 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 9 | 0.480 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2015 | 5 | 0.480 |
Why?
|
| Sheep | 13 | 2024 | 233 | 0.480 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2015 | 1 | 0.480 |
Why?
|
| Smad3 Protein | 1 | 2015 | 8 | 0.480 |
Why?
|
| Fullerenes | 1 | 2015 | 3 | 0.480 |
Why?
|
| Integrin alpha5beta1 | 1 | 2015 | 2 | 0.480 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2015 | 55 | 0.480 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2015 | 2 | 0.480 |
Why?
|
| Cystadenocarcinoma | 1 | 2015 | 3 | 0.480 |
Why?
|
| Health Systems Agencies | 1 | 2015 | 2 | 0.480 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2015 | 6 | 0.480 |
Why?
|
| Kidney Failure, Chronic | 8 | 2015 | 543 | 0.480 |
Why?
|
| Rheology | 6 | 2020 | 32 | 0.480 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 34 | 0.480 |
Why?
|
| Cell Hypoxia | 2 | 2015 | 43 | 0.480 |
Why?
|
| Osteoclasts | 1 | 2015 | 24 | 0.480 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 23 | 0.480 |
Why?
|
| Preoptic Area | 1 | 2015 | 5 | 0.470 |
Why?
|
| DNA, Intergenic | 1 | 2015 | 9 | 0.470 |
Why?
|
| Promoter Regions, Genetic | 4 | 2017 | 208 | 0.470 |
Why?
|
| Colonic Neoplasms | 2 | 2015 | 74 | 0.470 |
Why?
|
| Autophagy | 1 | 2016 | 55 | 0.470 |
Why?
|
| Social Responsibility | 1 | 2015 | 14 | 0.470 |
Why?
|
| Epithelium | 1 | 2015 | 22 | 0.470 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 19 | 0.470 |
Why?
|
| Lung Injury | 2 | 2015 | 67 | 0.470 |
Why?
|
| Forecasting | 6 | 2015 | 143 | 0.470 |
Why?
|
| Urodynamics | 7 | 2020 | 36 | 0.470 |
Why?
|
| Pulmonary Valve | 1 | 2015 | 11 | 0.470 |
Why?
|
| Military Medicine | 1 | 2015 | 26 | 0.470 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 65 | 0.470 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2015 | 1 | 0.470 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 117 | 0.470 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2015 | 3 | 0.470 |
Why?
|
| Ribonuclease III | 1 | 2015 | 3 | 0.470 |
Why?
|
| Virulence | 4 | 2019 | 22 | 0.470 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 9 | 0.470 |
Why?
|
| Neoplasms, Experimental | 3 | 2014 | 30 | 0.470 |
Why?
|
| Skin Transplantation | 4 | 2023 | 49 | 0.470 |
Why?
|
| Alternative Splicing | 1 | 2015 | 32 | 0.460 |
Why?
|
| Carbon | 1 | 2015 | 11 | 0.460 |
Why?
|
| Nephrons | 1 | 2015 | 10 | 0.460 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2015 | 2 | 0.460 |
Why?
|
| Heparin | 6 | 2020 | 70 | 0.460 |
Why?
|
| Retrospective Studies | 5 | 2022 | 3701 | 0.460 |
Why?
|
| Macular Degeneration | 2 | 2014 | 27 | 0.460 |
Why?
|
| TRPM Cation Channels | 1 | 2015 | 4 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 19 | 0.460 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 9 | 0.460 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2015 | 1 | 0.460 |
Why?
|
| TRPP Cation Channels | 1 | 2015 | 2 | 0.460 |
Why?
|
| Cilia | 1 | 2015 | 4 | 0.460 |
Why?
|
| Trachea | 5 | 2019 | 52 | 0.460 |
Why?
|
| Receptors, Chemokine | 1 | 2015 | 11 | 0.460 |
Why?
|
| GTP-Binding Proteins | 1 | 2015 | 24 | 0.460 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2015 | 5 | 0.450 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 835 | 0.450 |
Why?
|
| Cation Transport Proteins | 1 | 2015 | 24 | 0.450 |
Why?
|
| Morphinans | 1 | 2014 | 1 | 0.450 |
Why?
|
| Phthalimides | 1 | 2014 | 1 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2014 | 1 | 0.450 |
Why?
|
| Endogenous Retroviruses | 1 | 2014 | 2 | 0.450 |
Why?
|
| Keratins | 8 | 2013 | 37 | 0.450 |
Why?
|
| Gene Products, env | 1 | 2014 | 2 | 0.450 |
Why?
|
| Contrast Media | 1 | 2015 | 138 | 0.450 |
Why?
|
| Mitoxantrone | 1 | 2015 | 19 | 0.450 |
Why?
|
| Brain | 4 | 2020 | 946 | 0.450 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2014 | 15 | 0.450 |
Why?
|
| Biological Specimen Banks | 1 | 2015 | 9 | 0.450 |
Why?
|
| Pregnancy Proteins | 1 | 2014 | 10 | 0.450 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 70 | 0.450 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2014 | 1 | 0.450 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 40 | 0.450 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 36 | 0.450 |
Why?
|
| Chromosomal Instability | 1 | 2014 | 5 | 0.450 |
Why?
|
| Drug Industry | 1 | 2015 | 17 | 0.450 |
Why?
|
| Cattle | 11 | 2015 | 108 | 0.450 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2014 | 1 | 0.450 |
Why?
|
| Lipodystrophy, Congenital Generalized | 1 | 2014 | 1 | 0.450 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2014 | 4 | 0.450 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 22 | 0.450 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 69 | 0.450 |
Why?
|
| Fertilization | 1 | 2014 | 5 | 0.450 |
Why?
|
| Pheromones | 1 | 2014 | 3 | 0.450 |
Why?
|
| Carrier Proteins | 1 | 2015 | 136 | 0.440 |
Why?
|
| Weight-Bearing | 1 | 2015 | 40 | 0.440 |
Why?
|
| Morpholines | 1 | 2014 | 38 | 0.440 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 23 | 0.440 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 105 | 0.440 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2014 | 10 | 0.440 |
Why?
|
| Wilms Tumor | 1 | 2014 | 14 | 0.440 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 45 | 0.440 |
Why?
|
| Rats, Nude | 11 | 2020 | 43 | 0.440 |
Why?
|
| Vitamins | 1 | 2015 | 73 | 0.440 |
Why?
|
| Burns | 3 | 2023 | 100 | 0.440 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2014 | 12 | 0.440 |
Why?
|
| Protein Engineering | 2 | 2014 | 19 | 0.440 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 20 | 0.440 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 57 | 0.440 |
Why?
|
| Peroxiredoxins | 1 | 2015 | 116 | 0.440 |
Why?
|
| Case-Control Studies | 6 | 2016 | 876 | 0.440 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 88 | 0.440 |
Why?
|
| Acetanilides | 1 | 2014 | 5 | 0.440 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2014 | 38 | 0.440 |
Why?
|
| Databases, Factual | 1 | 2016 | 369 | 0.440 |
Why?
|
| Models, Animal | 9 | 2024 | 171 | 0.430 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2014 | 6 | 0.430 |
Why?
|
| Kidney Tubules | 2 | 2013 | 26 | 0.430 |
Why?
|
| Analgesics, Opioid | 2 | 2014 | 252 | 0.430 |
Why?
|
| Nitroso Compounds | 1 | 2014 | 2 | 0.430 |
Why?
|
| Sex Characteristics | 1 | 2015 | 172 | 0.430 |
Why?
|
| Homeodomain Proteins | 5 | 2019 | 52 | 0.430 |
Why?
|
| Meat Products | 1 | 2014 | 3 | 0.430 |
Why?
|
| Carbazoles | 1 | 2014 | 6 | 0.430 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2014 | 25 | 0.430 |
Why?
|
| Thiazoles | 1 | 2014 | 27 | 0.430 |
Why?
|
| Propanolamines | 1 | 2014 | 11 | 0.430 |
Why?
|
| Bone Regeneration | 6 | 2022 | 33 | 0.430 |
Why?
|
| Mullerian Ducts | 1 | 2014 | 3 | 0.430 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 15 | 0.430 |
Why?
|
| Neurons, Afferent | 1 | 2014 | 55 | 0.430 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 69 | 0.430 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 3 | 2020 | 4 | 0.430 |
Why?
|
| Receptors, Leptin | 1 | 2014 | 6 | 0.430 |
Why?
|
| Heart | 7 | 2017 | 185 | 0.430 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 11 | 0.430 |
Why?
|
| Congenital Abnormalities | 1 | 2014 | 10 | 0.430 |
Why?
|
| Culture Media | 7 | 2018 | 45 | 0.430 |
Why?
|
| Keratinocytes | 4 | 2020 | 29 | 0.430 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2017 | 62 | 0.430 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2014 | 3 | 0.430 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2014 | 15 | 0.430 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 6 | 0.420 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2014 | 4 | 0.420 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 92 | 0.420 |
Why?
|
| Immune Tolerance | 2 | 2015 | 70 | 0.420 |
Why?
|
| Organ Preservation | 1 | 2014 | 37 | 0.420 |
Why?
|
| Renin | 1 | 2014 | 109 | 0.420 |
Why?
|
| Mutation, Missense | 2 | 2013 | 51 | 0.420 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2013 | 3 | 0.420 |
Why?
|
| Genes, p53 | 1 | 2013 | 23 | 0.420 |
Why?
|
| Anion Transport Proteins | 1 | 2013 | 2 | 0.420 |
Why?
|
| Glycogen | 1 | 2013 | 3 | 0.420 |
Why?
|
| Air Pollutants, Occupational | 1 | 2013 | 4 | 0.420 |
Why?
|
| Leptin | 1 | 2014 | 73 | 0.420 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2013 | 1 | 0.420 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2013 | 6 | 0.420 |
Why?
|
| Antiporters | 1 | 2013 | 9 | 0.410 |
Why?
|
| Benzhydryl Compounds | 1 | 2013 | 8 | 0.410 |
Why?
|
| Phenols | 1 | 2013 | 18 | 0.410 |
Why?
|
| Tensile Strength | 10 | 2017 | 56 | 0.410 |
Why?
|
| Goals | 1 | 2014 | 35 | 0.410 |
Why?
|
| Type C Phospholipases | 1 | 2013 | 7 | 0.410 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2013 | 7 | 0.410 |
Why?
|
| Glutamic Acid | 1 | 2014 | 47 | 0.410 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2013 | 8 | 0.410 |
Why?
|
| Endoscopy | 1 | 2014 | 56 | 0.410 |
Why?
|
| Ovum | 1 | 2013 | 2 | 0.410 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 240 | 0.410 |
Why?
|
| Thymus Gland | 1 | 2013 | 16 | 0.410 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 10 | 0.410 |
Why?
|
| Bombesin | 1 | 2013 | 2 | 0.410 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2013 | 3 | 0.410 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 5 | 0.410 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 167 | 0.410 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2013 | 6 | 0.400 |
Why?
|
| Cell Size | 1 | 2013 | 36 | 0.400 |
Why?
|
| Corticosterone | 1 | 2013 | 7 | 0.400 |
Why?
|
| Information Dissemination | 1 | 2014 | 55 | 0.400 |
Why?
|
| Urinary Incontinence | 2 | 2012 | 48 | 0.400 |
Why?
|
| Middle Aged | 20 | 2022 | 12126 | 0.400 |
Why?
|
| Hormone Replacement Therapy | 3 | 2019 | 89 | 0.400 |
Why?
|
| Gene Expression | 12 | 2022 | 334 | 0.400 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 43 | 0.400 |
Why?
|
| Indoles | 1 | 2013 | 56 | 0.400 |
Why?
|
| Pyrazoles | 1 | 2013 | 68 | 0.390 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 65 | 0.390 |
Why?
|
| Nanotechnology | 3 | 2016 | 18 | 0.390 |
Why?
|
| Blotting, Western | 10 | 2017 | 287 | 0.390 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 87 | 0.390 |
Why?
|
| Sulfonamides | 1 | 2013 | 67 | 0.390 |
Why?
|
| Calcium Channels | 1 | 2013 | 61 | 0.390 |
Why?
|
| Colon | 1 | 2013 | 51 | 0.390 |
Why?
|
| Mouth Mucosa | 3 | 2014 | 30 | 0.390 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 178 | 0.390 |
Why?
|
| Microfluidics | 3 | 2017 | 18 | 0.380 |
Why?
|
| Treatment Outcome | 11 | 2016 | 3438 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2016 | 28 | 0.380 |
Why?
|
| Alginates | 6 | 2018 | 52 | 0.380 |
Why?
|
| Microscopy, Fluorescence | 7 | 2019 | 91 | 0.380 |
Why?
|
| Carcinoma | 1 | 2013 | 92 | 0.380 |
Why?
|
| Mucous Membrane | 5 | 2018 | 21 | 0.370 |
Why?
|
| Spinal Cord | 1 | 2013 | 121 | 0.370 |
Why?
|
| Fetal Stem Cells | 4 | 2015 | 10 | 0.370 |
Why?
|
| Muscle, Striated | 1 | 2012 | 4 | 0.370 |
Why?
|
| Parthenogenesis | 2 | 2009 | 7 | 0.370 |
Why?
|
| Penile Diseases | 1 | 2011 | 3 | 0.370 |
Why?
|
| Flow Cytometry | 12 | 2016 | 186 | 0.370 |
Why?
|
| Nitric Oxide | 5 | 2019 | 111 | 0.360 |
Why?
|
| Clinical Medicine | 2 | 2009 | 13 | 0.360 |
Why?
|
| Clinical Trials as Topic | 5 | 2017 | 307 | 0.360 |
Why?
|
| Diet | 1 | 2014 | 390 | 0.360 |
Why?
|
| Tissue Culture Techniques | 3 | 2011 | 39 | 0.360 |
Why?
|
| Intestine, Small | 3 | 2022 | 40 | 0.360 |
Why?
|
| Epidermis | 2 | 2023 | 29 | 0.350 |
Why?
|
| Anilides | 1 | 2011 | 11 | 0.350 |
Why?
|
| Sexual Behavior, Animal | 1 | 2011 | 8 | 0.350 |
Why?
|
| North Carolina | 4 | 2016 | 1546 | 0.350 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2011 | 2 | 0.350 |
Why?
|
| Diabetes Mellitus | 3 | 2016 | 422 | 0.350 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2011 | 3 | 0.350 |
Why?
|
| Equipment Design | 5 | 2020 | 179 | 0.350 |
Why?
|
| Metallothionein | 1 | 2011 | 3 | 0.350 |
Why?
|
| Carcinogens, Environmental | 1 | 2011 | 2 | 0.350 |
Why?
|
| Lead | 1 | 2011 | 6 | 0.350 |
Why?
|
| Stress, Psychological | 1 | 2013 | 226 | 0.350 |
Why?
|
| Maternal Exposure | 1 | 2011 | 11 | 0.350 |
Why?
|
| Dependovirus | 2 | 2022 | 19 | 0.340 |
Why?
|
| Spinal Nerve Roots | 1 | 2011 | 13 | 0.340 |
Why?
|
| Reflex | 1 | 2011 | 16 | 0.340 |
Why?
|
| Porosity | 10 | 2022 | 39 | 0.340 |
Why?
|
| Interleukin-2 | 1 | 2011 | 33 | 0.340 |
Why?
|
| Transplantation | 3 | 2019 | 13 | 0.340 |
Why?
|
| Biomimetic Materials | 4 | 2020 | 15 | 0.340 |
Why?
|
| Feasibility Studies | 9 | 2020 | 308 | 0.330 |
Why?
|
| Insulin | 3 | 2018 | 367 | 0.330 |
Why?
|
| Aging | 2 | 2014 | 938 | 0.330 |
Why?
|
| Peptide Fragments | 1 | 2013 | 403 | 0.330 |
Why?
|
| Cells | 1 | 2010 | 4 | 0.320 |
Why?
|
| Insulin-Secreting Cells | 2 | 2012 | 53 | 0.320 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2020 | 90 | 0.320 |
Why?
|
| Corrosion Casting | 3 | 2021 | 10 | 0.310 |
Why?
|
| Urethral Obstruction | 1 | 2009 | 4 | 0.310 |
Why?
|
| Cell Division | 7 | 2005 | 94 | 0.310 |
Why?
|
| Gene Expression Regulation | 8 | 2016 | 475 | 0.310 |
Why?
|
| Muscles | 5 | 2013 | 63 | 0.310 |
Why?
|
| Collagen Type I | 5 | 2013 | 42 | 0.310 |
Why?
|
| Prostatectomy | 2 | 2020 | 83 | 0.310 |
Why?
|
| Elastin | 2 | 2008 | 14 | 0.310 |
Why?
|
| Satellite Cells, Skeletal Muscle | 2 | 2014 | 8 | 0.310 |
Why?
|
| Adenoviridae | 4 | 2013 | 68 | 0.310 |
Why?
|
| United States | 5 | 2015 | 4109 | 0.300 |
Why?
|
| Embryo, Mammalian | 5 | 2008 | 28 | 0.300 |
Why?
|
| Exosomes | 2 | 2021 | 44 | 0.300 |
Why?
|
| Prognosis | 4 | 2019 | 1544 | 0.300 |
Why?
|
| Coculture Techniques | 7 | 2015 | 80 | 0.300 |
Why?
|
| Nanostructures | 4 | 2009 | 21 | 0.300 |
Why?
|
| Tendons | 3 | 2014 | 59 | 0.290 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2020 | 27 | 0.290 |
Why?
|
| Prostheses and Implants | 4 | 2020 | 47 | 0.290 |
Why?
|
| Surgical Flaps | 4 | 2015 | 77 | 0.290 |
Why?
|
| Granulosa Cells | 2 | 2019 | 11 | 0.290 |
Why?
|
| Base Sequence | 5 | 2019 | 247 | 0.290 |
Why?
|
| Time Factors | 13 | 2020 | 2183 | 0.290 |
Why?
|
| Muscular Diseases | 2 | 2020 | 23 | 0.290 |
Why?
|
| Urogenital Abnormalities | 1 | 2008 | 3 | 0.280 |
Why?
|
| Fetus | 4 | 2023 | 86 | 0.280 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2020 | 13 | 0.280 |
Why?
|
| Erythropoietin | 4 | 2012 | 31 | 0.280 |
Why?
|
| Green Fluorescent Proteins | 4 | 2019 | 72 | 0.280 |
Why?
|
| Mice, SCID | 6 | 2015 | 71 | 0.280 |
Why?
|
| Software | 3 | 2016 | 124 | 0.270 |
Why?
|
| Fimbriae Proteins | 2 | 2017 | 5 | 0.270 |
Why?
|
| Automation | 2 | 2018 | 30 | 0.270 |
Why?
|
| Valproic Acid | 3 | 2012 | 14 | 0.270 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2012 | 21 | 0.270 |
Why?
|
| Mitochondria | 4 | 2016 | 206 | 0.270 |
Why?
|
| Actins | 3 | 2015 | 51 | 0.270 |
Why?
|
| Infant, Newborn | 8 | 2014 | 694 | 0.270 |
Why?
|
| Phosphorylation | 4 | 2017 | 226 | 0.270 |
Why?
|
| History, 21st Century | 2 | 2020 | 61 | 0.270 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2019 | 134 | 0.260 |
Why?
|
| Histone Demethylases | 2 | 2017 | 8 | 0.260 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 193 | 0.260 |
Why?
|
| Quality Control | 2 | 2018 | 43 | 0.260 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2019 | 12 | 0.250 |
Why?
|
| Cell Cycle Proteins | 2 | 2018 | 56 | 0.250 |
Why?
|
| Cells, Immobilized | 3 | 2016 | 22 | 0.250 |
Why?
|
| Leydig Cells | 2 | 2003 | 3 | 0.250 |
Why?
|
| Calcium | 7 | 2018 | 323 | 0.250 |
Why?
|
| Nanotubes, Carbon | 1 | 2006 | 23 | 0.250 |
Why?
|
| Macrophages | 2 | 2019 | 194 | 0.250 |
Why?
|
| Bacteria | 2 | 2017 | 55 | 0.250 |
Why?
|
| Luteinizing Hormone | 3 | 2022 | 15 | 0.250 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2020 | 4 | 0.240 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2022 | 28 | 0.240 |
Why?
|
| Myosins | 3 | 2013 | 11 | 0.240 |
Why?
|
| Hemofiltration | 1 | 2006 | 3 | 0.240 |
Why?
|
| General Surgery | 2 | 2020 | 86 | 0.240 |
Why?
|
| Embryo Research | 1 | 2005 | 1 | 0.240 |
Why?
|
| Postoperative Care | 3 | 2019 | 78 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2019 | 255 | 0.240 |
Why?
|
| Biotechnology | 2 | 2018 | 8 | 0.240 |
Why?
|
| Transplantation, Heterologous | 9 | 2020 | 122 | 0.240 |
Why?
|
| Peripheral Nerves | 3 | 2012 | 63 | 0.240 |
Why?
|
| Polyethylene Glycols | 2 | 2016 | 64 | 0.240 |
Why?
|
| Glycolates | 1 | 2005 | 7 | 0.240 |
Why?
|
| Adipogenesis | 3 | 2020 | 30 | 0.240 |
Why?
|
| Transplants | 4 | 2015 | 23 | 0.230 |
Why?
|
| Chronic Disease | 2 | 2004 | 410 | 0.230 |
Why?
|
| Mechanical Phenomena | 3 | 2015 | 28 | 0.230 |
Why?
|
| Ear Cartilage | 3 | 2020 | 12 | 0.230 |
Why?
|
| Sciatic Nerve | 2 | 2012 | 36 | 0.230 |
Why?
|
| Mandible | 2 | 2016 | 39 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2016 | 95 | 0.230 |
Why?
|
| Culture Techniques | 3 | 2017 | 14 | 0.230 |
Why?
|
| Graft Survival | 4 | 2017 | 313 | 0.230 |
Why?
|
| Ovary | 2 | 2017 | 58 | 0.230 |
Why?
|
| Neoplasm Metastasis | 2 | 2016 | 220 | 0.230 |
Why?
|
| Cell-Free System | 4 | 2015 | 16 | 0.230 |
Why?
|
| Sepsis | 2 | 2017 | 165 | 0.230 |
Why?
|
| Pelvic Floor | 2 | 2020 | 20 | 0.230 |
Why?
|
| Mutagenesis | 2 | 2017 | 31 | 0.230 |
Why?
|
| Larynx | 3 | 2014 | 19 | 0.220 |
Why?
|
| Semen Preservation | 2 | 2021 | 3 | 0.220 |
Why?
|
| Rats, Inbred F344 | 4 | 2019 | 134 | 0.220 |
Why?
|
| Micromanipulation | 1 | 2004 | 2 | 0.220 |
Why?
|
| Vasodilator Agents | 3 | 2020 | 59 | 0.220 |
Why?
|
| Centrifugation | 1 | 2004 | 3 | 0.220 |
Why?
|
| Antigens, Differentiation | 2 | 2015 | 25 | 0.220 |
Why?
|
| Liver Diseases | 2 | 2019 | 74 | 0.220 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 73 | 0.210 |
Why?
|
| Pilot Projects | 5 | 2014 | 565 | 0.210 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 71 | 0.210 |
Why?
|
| Membrane Glycoproteins | 3 | 2019 | 98 | 0.210 |
Why?
|
| Organ Specificity | 4 | 2017 | 80 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 6 | 2018 | 789 | 0.210 |
Why?
|
| Cell Nucleus | 4 | 2020 | 105 | 0.210 |
Why?
|
| Hemoglobins | 1 | 2024 | 49 | 0.210 |
Why?
|
| Muscle Cells | 1 | 2003 | 7 | 0.210 |
Why?
|
| Protein Transport | 3 | 2019 | 72 | 0.210 |
Why?
|
| SOXB1 Transcription Factors | 4 | 2017 | 18 | 0.210 |
Why?
|
| Genes, Reporter | 3 | 2020 | 39 | 0.210 |
Why?
|
| Biological Transport | 2 | 2020 | 68 | 0.200 |
Why?
|
| Aged | 8 | 2016 | 10538 | 0.200 |
Why?
|
| Polylysine | 1 | 2003 | 5 | 0.200 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 46 | 0.200 |
Why?
|
| Gene Targeting | 1 | 2003 | 16 | 0.200 |
Why?
|
| Drug Compounding | 2 | 2016 | 36 | 0.200 |
Why?
|
| Body Fluids | 1 | 2023 | 8 | 0.200 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 31 | 0.200 |
Why?
|
| Prosthesis Implantation | 5 | 2015 | 39 | 0.200 |
Why?
|
| Cell Adhesion | 10 | 2015 | 103 | 0.200 |
Why?
|
| Isoenzymes | 1 | 2003 | 59 | 0.200 |
Why?
|
| Cell Membrane Permeability | 2 | 2020 | 18 | 0.200 |
Why?
|
| Young Adult | 8 | 2022 | 2730 | 0.200 |
Why?
|
| Synovial Fluid | 1 | 2023 | 8 | 0.200 |
Why?
|
| Tracheal Diseases | 2 | 2014 | 5 | 0.200 |
Why?
|
| Injections, Intra-Articular | 1 | 2023 | 16 | 0.200 |
Why?
|
| Laryngeal Diseases | 2 | 2014 | 9 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2015 | 1307 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2022 | 100 | 0.200 |
Why?
|
| Neovascularization, Pathologic | 6 | 2013 | 80 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2023 | 108 | 0.200 |
Why?
|
| Elasticity | 3 | 2018 | 38 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2019 | 83 | 0.190 |
Why?
|
| Proteoglycans | 2 | 2019 | 29 | 0.190 |
Why?
|
| Graphite | 1 | 2022 | 5 | 0.190 |
Why?
|
| Lentivirus | 2 | 2019 | 10 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 4 | 2016 | 160 | 0.190 |
Why?
|
| Tissue Survival | 2 | 2015 | 13 | 0.190 |
Why?
|
| Cystectomy | 2 | 2017 | 106 | 0.190 |
Why?
|
| Perfusion | 4 | 2016 | 74 | 0.190 |
Why?
|
| Tissue Expansion | 1 | 2002 | 4 | 0.190 |
Why?
|
| Histocompatibility | 1 | 2002 | 7 | 0.190 |
Why?
|
| Theca Cells | 2 | 2019 | 9 | 0.190 |
Why?
|
| Luciferases | 3 | 2019 | 31 | 0.190 |
Why?
|
| Skin Physiological Phenomena | 1 | 2002 | 7 | 0.190 |
Why?
|
| DNA Damage | 2 | 2018 | 93 | 0.190 |
Why?
|
| Animals, Newborn | 2 | 2021 | 119 | 0.190 |
Why?
|
| Acute Lung Injury | 1 | 2022 | 37 | 0.190 |
Why?
|
| Fistula | 1 | 2002 | 11 | 0.190 |
Why?
|
| Tissue Adhesions | 1 | 2022 | 12 | 0.190 |
Why?
|
| Pneumonia | 1 | 2022 | 64 | 0.190 |
Why?
|
| Bone Marrow Cells | 3 | 2022 | 123 | 0.180 |
Why?
|
| Chemokine CCL2 | 2 | 2019 | 48 | 0.180 |
Why?
|
| Viscosity | 3 | 2018 | 23 | 0.180 |
Why?
|
| Abdomen | 1 | 2022 | 46 | 0.180 |
Why?
|
| Staphylococcus aureus | 2 | 2019 | 54 | 0.180 |
Why?
|
| Organogenesis | 3 | 2018 | 18 | 0.180 |
Why?
|
| Exons | 2 | 2020 | 52 | 0.180 |
Why?
|
| Elastic Modulus | 4 | 2019 | 27 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2016 | 100 | 0.170 |
Why?
|
| Neuromuscular Junction | 3 | 2020 | 66 | 0.170 |
Why?
|
| Estrogens | 2 | 2019 | 169 | 0.170 |
Why?
|
| Heart Valves | 2 | 2011 | 16 | 0.170 |
Why?
|
| Databases as Topic | 2 | 2015 | 21 | 0.170 |
Why?
|
| Receptors, Cholinergic | 3 | 2013 | 22 | 0.170 |
Why?
|
| SOX9 Transcription Factor | 1 | 2021 | 12 | 0.170 |
Why?
|
| Biological Assay | 2 | 2023 | 18 | 0.170 |
Why?
|
| Clone Cells | 4 | 2013 | 35 | 0.170 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 27 | 0.170 |
Why?
|
| Reading Frames | 1 | 2020 | 2 | 0.170 |
Why?
|
| Hypercalciuria | 1 | 2020 | 1 | 0.170 |
Why?
|
| Cullin Proteins | 1 | 2020 | 6 | 0.170 |
Why?
|
| Down-Regulation | 2 | 2014 | 134 | 0.170 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 7 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2023 | 43 | 0.170 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 47 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 84 | 0.160 |
Why?
|
| Progesterone | 2 | 2019 | 69 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 102 | 0.160 |
Why?
|
| Anemia | 2 | 2012 | 57 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 20 | 0.160 |
Why?
|
| Ischemia | 2 | 2020 | 104 | 0.160 |
Why?
|
| Remote Consultation | 1 | 2020 | 12 | 0.160 |
Why?
|
| Astemizole | 1 | 2020 | 5 | 0.160 |
Why?
|
| Loss of Heterozygosity | 1 | 2020 | 20 | 0.160 |
Why?
|
| Chromosomes | 1 | 2020 | 9 | 0.160 |
Why?
|
| Chemokines | 1 | 2020 | 33 | 0.160 |
Why?
|
| Ifosfamide | 1 | 2020 | 6 | 0.160 |
Why?
|
| Astrocytes | 1 | 2020 | 57 | 0.160 |
Why?
|
| Staining and Labeling | 3 | 2015 | 57 | 0.160 |
Why?
|
| 5-Methylcytosine | 1 | 2020 | 2 | 0.160 |
Why?
|
| Osteoblasts | 3 | 2012 | 44 | 0.160 |
Why?
|
| Tissue Donors | 3 | 2019 | 207 | 0.160 |
Why?
|
| Prodrugs | 1 | 2020 | 16 | 0.160 |
Why?
|
| Penicillin G | 1 | 2020 | 2 | 0.160 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 17 | 0.160 |
Why?
|
| Inhibins | 1 | 2020 | 4 | 0.160 |
Why?
|
| Trauma, Nervous System | 1 | 2020 | 9 | 0.160 |
Why?
|
| Outpatients | 1 | 2020 | 57 | 0.160 |
Why?
|
| Regulon | 1 | 2019 | 1 | 0.160 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 49 | 0.160 |
Why?
|
| Rats, Inbred Lew | 7 | 2015 | 120 | 0.160 |
Why?
|
| Genetic Engineering | 3 | 2012 | 18 | 0.160 |
Why?
|
| Fluoroquinolones | 1 | 2019 | 11 | 0.160 |
Why?
|
| Genes, Suppressor | 1 | 2019 | 2 | 0.160 |
Why?
|
| Oncogenes | 1 | 2019 | 14 | 0.160 |
Why?
|
| Metabolome | 1 | 2020 | 37 | 0.160 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 91 | 0.160 |
Why?
|
| Meningomyelocele | 3 | 2012 | 9 | 0.160 |
Why?
|
| Pericardium | 1 | 2020 | 55 | 0.160 |
Why?
|
| Hemangioma | 2 | 2012 | 22 | 0.160 |
Why?
|
| Electric Stimulation | 3 | 2008 | 106 | 0.160 |
Why?
|
| Phenylthiohydantoin | 1 | 2019 | 8 | 0.160 |
Why?
|
| Delayed-Action Preparations | 4 | 2017 | 36 | 0.160 |
Why?
|
| Hydroxysteroids | 1 | 2019 | 1 | 0.160 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 15 | 0.160 |
Why?
|
| Aspirin | 1 | 2020 | 62 | 0.150 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 15 | 0.150 |
Why?
|
| Calcium Oxalate | 1 | 2019 | 3 | 0.150 |
Why?
|
| Heart Rate | 2 | 2020 | 343 | 0.150 |
Why?
|
| Prosthesis Design | 4 | 2015 | 102 | 0.150 |
Why?
|
| Toxicity Tests | 2 | 2017 | 13 | 0.150 |
Why?
|
| RNA, Guide | 1 | 2019 | 3 | 0.150 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 38 | 0.150 |
Why?
|
| Implants, Experimental | 3 | 2019 | 12 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 11 | 0.150 |
Why?
|
| Injections | 4 | 2013 | 63 | 0.150 |
Why?
|
| Technology | 1 | 2019 | 11 | 0.150 |
Why?
|
| E2F1 Transcription Factor | 1 | 2019 | 4 | 0.150 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2019 | 10 | 0.150 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2019 | 2 | 0.150 |
Why?
|
| Sequence Alignment | 1 | 2019 | 60 | 0.150 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 17 | 0.150 |
Why?
|
| Keloid | 1 | 2019 | 8 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2019 | 76 | 0.150 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2019 | 3 | 0.150 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 79 | 0.150 |
Why?
|
| Ubiquitination | 1 | 2019 | 16 | 0.150 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 107 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2011 | 2284 | 0.150 |
Why?
|
| Factor VIII | 3 | 2023 | 25 | 0.150 |
Why?
|
| Liver, Artificial | 2 | 2016 | 5 | 0.150 |
Why?
|
| Product Labeling | 1 | 2019 | 19 | 0.150 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 169 | 0.150 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2018 | 4 | 0.150 |
Why?
|
| Renal Insufficiency | 2 | 2012 | 57 | 0.140 |
Why?
|
| Industry | 1 | 2018 | 15 | 0.140 |
Why?
|
| Peptidoglycan | 1 | 2018 | 2 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 98 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 102 | 0.140 |
Why?
|
| Telemedicine | 1 | 2020 | 117 | 0.140 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 647 | 0.140 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 25 | 0.140 |
Why?
|
| Hair | 2 | 2009 | 28 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2022 | 1844 | 0.140 |
Why?
|
| Polysaccharides | 1 | 2018 | 14 | 0.140 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2018 | 18 | 0.140 |
Why?
|
| Necrosis | 1 | 2018 | 51 | 0.140 |
Why?
|
| Morphogenesis | 1 | 2018 | 5 | 0.140 |
Why?
|
| Electrophysiological Phenomena | 3 | 2012 | 26 | 0.140 |
Why?
|
| Pancreas | 3 | 2015 | 103 | 0.140 |
Why?
|
| Monitoring, Immunologic | 1 | 2018 | 2 | 0.140 |
Why?
|
| Pseudomonas | 1 | 2018 | 6 | 0.140 |
Why?
|
| Receptors, CCR4 | 1 | 2018 | 3 | 0.140 |
Why?
|
| Chemokine CXCL12 | 3 | 2016 | 22 | 0.140 |
Why?
|
| Enterobacteriaceae | 1 | 2018 | 11 | 0.140 |
Why?
|
| Kidney Medulla | 1 | 2018 | 29 | 0.140 |
Why?
|
| Albumins | 2 | 2015 | 44 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2019 | 246 | 0.140 |
Why?
|
| Intracellular Space | 3 | 2014 | 16 | 0.140 |
Why?
|
| Cholecalciferol | 1 | 2018 | 22 | 0.140 |
Why?
|
| Lipoproteins | 1 | 2018 | 86 | 0.140 |
Why?
|
| Biomimetics | 2 | 2016 | 6 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2018 | 29 | 0.140 |
Why?
|
| Corneal Transplantation | 2 | 2015 | 14 | 0.140 |
Why?
|
| Bile Ducts | 1 | 2018 | 20 | 0.140 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 30 | 0.140 |
Why?
|
| Sermorelin | 1 | 2017 | 1 | 0.140 |
Why?
|
| Ferrets | 4 | 2022 | 20 | 0.130 |
Why?
|
| Genes, Neoplasm | 1 | 2017 | 17 | 0.130 |
Why?
|
| Vascular Patency | 2 | 2014 | 70 | 0.130 |
Why?
|
| Natronobacterium | 1 | 2017 | 2 | 0.130 |
Why?
|
| DNA Primers | 3 | 2007 | 89 | 0.130 |
Why?
|
| Oxygen | 2 | 2008 | 144 | 0.130 |
Why?
|
| Animal Use Alternatives | 1 | 2017 | 3 | 0.130 |
Why?
|
| Proteus Infections | 1 | 2017 | 1 | 0.130 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 66 | 0.130 |
Why?
|
| Urinary Bladder Calculi | 1 | 2017 | 2 | 0.130 |
Why?
|
| Proteins | 3 | 2014 | 142 | 0.130 |
Why?
|
| Emulsions | 1 | 2017 | 7 | 0.130 |
Why?
|
| Transgenes | 3 | 2012 | 49 | 0.130 |
Why?
|
| Cell Shape | 5 | 2018 | 28 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 4 | 2013 | 37 | 0.130 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2016 | 6 | 0.130 |
Why?
|
| Prenatal Diagnosis | 2 | 2023 | 26 | 0.130 |
Why?
|
| Hexosamines | 1 | 2016 | 9 | 0.130 |
Why?
|
| Thyroxine | 1 | 2016 | 16 | 0.130 |
Why?
|
| Carboxylic Acids | 1 | 2016 | 2 | 0.130 |
Why?
|
| Hypothyroidism | 1 | 2016 | 12 | 0.130 |
Why?
|
| Thyroid Gland | 1 | 2016 | 15 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 309 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 9 | 0.130 |
Why?
|
| Meiosis | 1 | 2016 | 33 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2017 | 1066 | 0.130 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 2016 | 4 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2020 | 324 | 0.120 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2017 | 68 | 0.120 |
Why?
|
| X-Ray Microtomography | 2 | 2015 | 41 | 0.120 |
Why?
|
| Mutagens | 1 | 2016 | 3 | 0.120 |
Why?
|
| Tin | 1 | 2016 | 2 | 0.120 |
Why?
|
| Fibrin | 2 | 2013 | 6 | 0.120 |
Why?
|
| Models, Cardiovascular | 1 | 2016 | 30 | 0.120 |
Why?
|
| Microtubules | 1 | 2016 | 22 | 0.120 |
Why?
|
| RNA, Transfer | 1 | 2016 | 2 | 0.120 |
Why?
|
| Tissue Banks | 1 | 2016 | 14 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 19 | 0.120 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2016 | 9 | 0.120 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2015 | 7 | 0.120 |
Why?
|
| Tyrosine | 1 | 2016 | 23 | 0.120 |
Why?
|
| Publications | 1 | 2016 | 9 | 0.120 |
Why?
|
| Estradiol | 1 | 2016 | 121 | 0.120 |
Why?
|
| Portraits as Topic | 1 | 2015 | 4 | 0.120 |
Why?
|
| Hep G2 Cells | 4 | 2016 | 28 | 0.120 |
Why?
|
| Limit of Detection | 1 | 2015 | 15 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 71 | 0.120 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 57 | 0.120 |
Why?
|
| Cell Death | 2 | 2012 | 71 | 0.120 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 51 | 0.120 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 59 | 0.120 |
Why?
|
| Hydronephrosis | 3 | 2005 | 12 | 0.120 |
Why?
|
| Databases, Genetic | 1 | 2015 | 40 | 0.120 |
Why?
|
| Solutions | 1 | 2015 | 36 | 0.120 |
Why?
|
| Limbus Corneae | 1 | 2015 | 7 | 0.120 |
Why?
|
| Neutrophils | 1 | 2016 | 110 | 0.120 |
Why?
|
| Hematologic Diseases | 1 | 2015 | 23 | 0.120 |
Why?
|
| Urea | 1 | 2015 | 37 | 0.120 |
Why?
|
| Varicocele | 2 | 2005 | 3 | 0.120 |
Why?
|
| Antibodies | 1 | 2015 | 51 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 526 | 0.120 |
Why?
|
| Endothelium, Corneal | 1 | 2015 | 21 | 0.110 |
Why?
|
| Lymphocytes | 2 | 2012 | 59 | 0.110 |
Why?
|
| Computational Biology | 1 | 2015 | 94 | 0.110 |
Why?
|
| Blood Urea Nitrogen | 3 | 2011 | 12 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2016 | 453 | 0.110 |
Why?
|
| Tooth | 1 | 2015 | 2 | 0.110 |
Why?
|
| Adiposity | 1 | 2016 | 198 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2016 | 123 | 0.110 |
Why?
|
| Immunosuppression | 2 | 2013 | 120 | 0.110 |
Why?
|
| Kinetics | 5 | 2019 | 205 | 0.110 |
Why?
|
| beta-Galactosidase | 2 | 2005 | 20 | 0.110 |
Why?
|
| Intestines | 2 | 2012 | 60 | 0.110 |
Why?
|
| Fluorouracil | 1 | 2015 | 82 | 0.110 |
Why?
|
| Equipment Failure Analysis | 3 | 2016 | 42 | 0.110 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 4 | 0.110 |
Why?
|
| Neuropilin-1 | 2 | 2005 | 12 | 0.110 |
Why?
|
| Alkaline Phosphatase | 4 | 2019 | 33 | 0.110 |
Why?
|
| Lymphokines | 3 | 2002 | 11 | 0.110 |
Why?
|
| Endothelial Growth Factors | 3 | 2002 | 12 | 0.110 |
Why?
|
| Ear Auricle | 1 | 2014 | 5 | 0.110 |
Why?
|
| Hernia, Abdominal | 2 | 2011 | 9 | 0.100 |
Why?
|
| Consensus | 1 | 2014 | 87 | 0.100 |
Why?
|
| Waiting Lists | 1 | 2013 | 36 | 0.100 |
Why?
|
| Azacitidine | 2 | 2011 | 28 | 0.100 |
Why?
|
| Emergency Medicine | 1 | 2014 | 121 | 0.100 |
Why?
|
| Enterocytes | 1 | 2013 | 7 | 0.100 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2013 | 16 | 0.100 |
Why?
|
| Shear Strength | 2 | 2020 | 10 | 0.100 |
Why?
|
| Tissue Preservation | 1 | 2013 | 8 | 0.100 |
Why?
|
| Neurites | 1 | 2013 | 8 | 0.100 |
Why?
|
| Gonadotropins | 1 | 2012 | 3 | 0.100 |
Why?
|
| Replantation | 1 | 2013 | 15 | 0.100 |
Why?
|
| Ureteral Neoplasms | 1 | 2013 | 11 | 0.100 |
Why?
|
| Propranolol | 1 | 2012 | 17 | 0.100 |
Why?
|
| Peptide Hormones | 1 | 2012 | 10 | 0.100 |
Why?
|
| Skin Ulcer | 1 | 2012 | 11 | 0.100 |
Why?
|
| Saccule and Utricle | 1 | 2012 | 3 | 0.100 |
Why?
|
| Access to Information | 1 | 2013 | 15 | 0.100 |
Why?
|
| Isometric Contraction | 2 | 2002 | 23 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 28 | 0.100 |
Why?
|
| Steroids | 1 | 2012 | 34 | 0.100 |
Why?
|
| Social Control, Formal | 1 | 2012 | 4 | 0.100 |
Why?
|
| Ultrasonography | 3 | 2005 | 381 | 0.100 |
Why?
|
| Ureteral Obstruction | 2 | 2013 | 28 | 0.100 |
Why?
|
| Islets of Langerhans | 1 | 2013 | 76 | 0.100 |
Why?
|
| CHO Cells | 1 | 2012 | 24 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 9 | 0.100 |
Why?
|
| Ganciclovir | 1 | 2012 | 23 | 0.100 |
Why?
|
| Cricetinae | 1 | 2012 | 39 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 13 | 0.090 |
Why?
|
| Jugular Veins | 1 | 2012 | 26 | 0.090 |
Why?
|
| Glycosaminoglycans | 3 | 2015 | 20 | 0.090 |
Why?
|
| Hela Cells | 1 | 2012 | 80 | 0.090 |
Why?
|
| Culture Media, Conditioned | 4 | 2014 | 47 | 0.090 |
Why?
|
| Skin Neoplasms | 2 | 2012 | 217 | 0.090 |
Why?
|
| Microscopy, Confocal | 3 | 2019 | 71 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 45 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2012 | 46 | 0.090 |
Why?
|
| Muramidase | 1 | 2012 | 8 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 302 | 0.090 |
Why?
|
| Algorithms | 1 | 2015 | 511 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2012 | 101 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2013 | 182 | 0.090 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2012 | 48 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 100 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2012 | 41 | 0.090 |
Why?
|
| Substance P | 1 | 2011 | 21 | 0.090 |
Why?
|
| Fracture Healing | 1 | 2012 | 43 | 0.090 |
Why?
|
| Preoperative Care | 2 | 2002 | 122 | 0.090 |
Why?
|
| Robotics | 1 | 2013 | 127 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 83 | 0.090 |
Why?
|
| Biopsy | 2 | 2011 | 245 | 0.090 |
Why?
|
| Pericytes | 3 | 2020 | 33 | 0.090 |
Why?
|
| Cryoprotective Agents | 1 | 2011 | 10 | 0.090 |
Why?
|
| Mexico | 1 | 2011 | 72 | 0.090 |
Why?
|
| Quinazolinones | 1 | 2011 | 7 | 0.090 |
Why?
|
| Cystitis | 1 | 2010 | 7 | 0.080 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2010 | 14 | 0.080 |
Why?
|
| Cellulose | 1 | 2010 | 2 | 0.080 |
Why?
|
| Surface Properties | 4 | 2012 | 36 | 0.080 |
Why?
|
| Dermis | 1 | 2010 | 16 | 0.080 |
Why?
|
| Urinary Diversion | 1 | 2010 | 27 | 0.080 |
Why?
|
| Abdominal Wall | 1 | 2010 | 22 | 0.080 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 3 | 0.080 |
Why?
|
| Permeability | 1 | 2010 | 9 | 0.080 |
Why?
|
| Molecular Weight | 1 | 2010 | 42 | 0.080 |
Why?
|
| Piperidines | 1 | 2011 | 120 | 0.080 |
Why?
|
| Copulation | 1 | 2009 | 2 | 0.080 |
Why?
|
| Transplantation, Homologous | 3 | 2016 | 151 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2012 | 280 | 0.080 |
Why?
|
| Mice, Inbred Strains | 2 | 2011 | 46 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 4 | 2016 | 25 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Fetal Diseases | 1 | 2009 | 19 | 0.080 |
Why?
|
| Hemostatics | 1 | 2009 | 11 | 0.080 |
Why?
|
| Protein Kinases | 2 | 2015 | 28 | 0.080 |
Why?
|
| Foreskin | 1 | 2009 | 8 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2007 | 199 | 0.080 |
Why?
|
| Calcinosis | 1 | 2010 | 146 | 0.080 |
Why?
|
| Cell Fractionation | 1 | 2009 | 8 | 0.070 |
Why?
|
| Microspheres | 2 | 2012 | 44 | 0.070 |
Why?
|
| Ferric Compounds | 1 | 2008 | 15 | 0.070 |
Why?
|
| Tetrazolium Salts | 1 | 2008 | 5 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 412 | 0.070 |
Why?
|
| Tight Junctions | 2 | 2018 | 10 | 0.070 |
Why?
|
| Tibial Nerve | 1 | 2008 | 21 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2008 | 44 | 0.070 |
Why?
|
| Respiratory Mucosa | 1 | 2008 | 12 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 42 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2012 | 20 | 0.070 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2005 | 17 | 0.070 |
Why?
|
| Vaginal Diseases | 1 | 2008 | 7 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2012 | 16 | 0.070 |
Why?
|
| Femoral Nerve | 1 | 2008 | 6 | 0.070 |
Why?
|
| Kidney Cortex | 1 | 2008 | 25 | 0.070 |
Why?
|
| NIH 3T3 Cells | 4 | 2010 | 43 | 0.070 |
Why?
|
| Specialization | 1 | 2008 | 32 | 0.070 |
Why?
|
| Electrolytes | 1 | 2008 | 11 | 0.070 |
Why?
|
| Aspartate Aminotransferases | 1 | 2008 | 28 | 0.070 |
Why?
|
| Urinalysis | 1 | 2008 | 26 | 0.070 |
Why?
|
| Blood Cell Count | 1 | 2008 | 27 | 0.070 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 46 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 238 | 0.070 |
Why?
|
| Research Embryo Creation | 1 | 2008 | 1 | 0.070 |
Why?
|
| Butorphanol | 1 | 2008 | 2 | 0.070 |
Why?
|
| Ethanol | 1 | 2010 | 191 | 0.070 |
Why?
|
| Orchiectomy | 2 | 2008 | 12 | 0.070 |
Why?
|
| Linear Models | 3 | 2005 | 445 | 0.070 |
Why?
|
| Administration, Intravesical | 2 | 2010 | 23 | 0.070 |
Why?
|
| Desmin | 3 | 2013 | 12 | 0.070 |
Why?
|
| Age Factors | 2 | 2008 | 1197 | 0.070 |
Why?
|
| Pruritus | 1 | 2008 | 47 | 0.070 |
Why?
|
| Agrin | 2 | 2020 | 8 | 0.070 |
Why?
|
| Quality of Life | 1 | 2013 | 961 | 0.070 |
Why?
|
| Biological Factors | 1 | 2007 | 10 | 0.070 |
Why?
|
| Vocal Cord Paralysis | 1 | 2007 | 5 | 0.070 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2007 | 10 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2007 | 7 | 0.070 |
Why?
|
| Hexuronic Acids | 2 | 2017 | 31 | 0.070 |
Why?
|
| Glucuronic Acid | 2 | 2017 | 31 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 576 | 0.060 |
Why?
|
| Radiography | 1 | 2008 | 386 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2007 | 79 | 0.060 |
Why?
|
| Karyotyping | 3 | 2012 | 28 | 0.060 |
Why?
|
| Homeostasis | 2 | 2004 | 135 | 0.060 |
Why?
|
| Polyglactin 910 | 1 | 2006 | 6 | 0.060 |
Why?
|
| Testicular Diseases | 1 | 2005 | 2 | 0.060 |
Why?
|
| Postoperative Period | 1 | 2006 | 99 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 105 | 0.060 |
Why?
|
| Suture Techniques | 2 | 2005 | 61 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 483 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factors | 4 | 2012 | 13 | 0.060 |
Why?
|
| Ethics, Research | 1 | 2005 | 23 | 0.060 |
Why?
|
| Organ Size | 2 | 2020 | 219 | 0.060 |
Why?
|
| Circumcision, Male | 1 | 2005 | 4 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2005 | 31 | 0.060 |
Why?
|
| Aquaporin 5 | 1 | 2005 | 4 | 0.060 |
Why?
|
| Biodegradation, Environmental | 1 | 2005 | 4 | 0.060 |
Why?
|
| Aquaporins | 1 | 2005 | 5 | 0.060 |
Why?
|
| alpha-Amylases | 1 | 2005 | 4 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2005 | 125 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 38 | 0.060 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2005 | 11 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2006 | 115 | 0.060 |
Why?
|
| Urination Disorders | 1 | 2004 | 5 | 0.060 |
Why?
|
| Bulbourethral Glands | 1 | 2004 | 1 | 0.060 |
Why?
|
| Lithotripsy | 1 | 2004 | 12 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2012 | 459 | 0.050 |
Why?
|
| Genital Diseases, Male | 1 | 2004 | 4 | 0.050 |
Why?
|
| Adipocytes | 1 | 2005 | 84 | 0.050 |
Why?
|
| Diverticulum | 1 | 2004 | 11 | 0.050 |
Why?
|
| Membranes, Artificial | 1 | 2004 | 8 | 0.050 |
Why?
|
| Cysts | 1 | 2004 | 17 | 0.050 |
Why?
|
| Genome, Human | 2 | 2017 | 132 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2004 | 4 | 0.050 |
Why?
|
| Cicatrix | 2 | 2017 | 39 | 0.050 |
Why?
|
| beta-Globins | 1 | 2024 | 2 | 0.050 |
Why?
|
| Genotype | 3 | 2014 | 731 | 0.050 |
Why?
|
| Hemoglobin A | 1 | 2024 | 2 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2004 | 17 | 0.050 |
Why?
|
| Hemoglobin, Sickle | 1 | 2024 | 8 | 0.050 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2004 | 11 | 0.050 |
Why?
|
| Endostatins | 1 | 2003 | 3 | 0.050 |
Why?
|
| von Willebrand Factor | 2 | 2016 | 14 | 0.050 |
Why?
|
| Nerve Endings | 1 | 2003 | 4 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2003 | 7 | 0.050 |
Why?
|
| DNA Repair | 1 | 2003 | 57 | 0.050 |
Why?
|
| Proteome | 1 | 2004 | 40 | 0.050 |
Why?
|
| Caspases | 1 | 2003 | 36 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2004 | 80 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2003 | 38 | 0.050 |
Why?
|
| Polyamines | 1 | 2003 | 11 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 2023 | 18 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2003 | 133 | 0.050 |
Why?
|
| Chick Embryo | 2 | 2013 | 61 | 0.050 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2013 | 23 | 0.050 |
Why?
|
| Detergents | 2 | 2013 | 16 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2002 | 24 | 0.050 |
Why?
|
| Seminiferous Tubules | 1 | 2022 | 3 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2003 | 63 | 0.050 |
Why?
|
| Urography | 1 | 2002 | 15 | 0.050 |
Why?
|
| Integrin alpha6 | 1 | 2022 | 3 | 0.050 |
Why?
|
| Electroplating | 1 | 2022 | 2 | 0.050 |
Why?
|
| Receptors, Adrenergic | 1 | 2002 | 7 | 0.050 |
Why?
|
| Hematoxylin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Paraffin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2022 | 5 | 0.050 |
Why?
|
| Receptors, Muscarinic | 1 | 2002 | 9 | 0.050 |
Why?
|
| Durapatite | 1 | 2022 | 10 | 0.050 |
Why?
|
| Constriction, Pathologic | 2 | 2013 | 47 | 0.050 |
Why?
|
| Semen | 1 | 2022 | 10 | 0.050 |
Why?
|
| Hydrochloric Acid | 1 | 2002 | 4 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 6 | 0.050 |
Why?
|
| Muscle Denervation | 2 | 2013 | 27 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2002 | 11 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 44 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 6 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2002 | 80 | 0.050 |
Why?
|
| Starch | 2 | 2012 | 8 | 0.050 |
Why?
|
| Growth Substances | 1 | 2002 | 7 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2022 | 59 | 0.050 |
Why?
|
| Laparoscopy | 1 | 2004 | 184 | 0.050 |
Why?
|
| Gene Products, gag | 1 | 2022 | 2 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2002 | 14 | 0.050 |
Why?
|
| Balanitis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Ion Channels | 1 | 2002 | 24 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2022 | 72 | 0.050 |
Why?
|
| Integrins | 1 | 2002 | 15 | 0.050 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2002 | 19 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2022 | 13 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 7 | 0.050 |
Why?
|
| Cytoskeleton | 2 | 2013 | 19 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2014 | 96 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 115 | 0.050 |
Why?
|
| Adenoviruses, Human | 1 | 2002 | 28 | 0.050 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2002 | 3 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 20 | 0.050 |
Why?
|
| Transducers | 1 | 2002 | 13 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 152 | 0.050 |
Why?
|
| MyoD Protein | 2 | 2014 | 9 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2022 | 29 | 0.050 |
Why?
|
| Mathematics | 1 | 2002 | 9 | 0.050 |
Why?
|
| Penile Implantation | 1 | 2002 | 7 | 0.050 |
Why?
|
| Gastrointestinal Tract | 2 | 2012 | 31 | 0.040 |
Why?
|
| Reoperation | 1 | 2002 | 260 | 0.040 |
Why?
|
| Absorption | 2 | 2012 | 15 | 0.040 |
Why?
|
| Mice, Inbred ICR | 2 | 2012 | 12 | 0.040 |
Why?
|
| Action Potentials | 2 | 2014 | 186 | 0.040 |
Why?
|
| Dystrophin | 1 | 2020 | 2 | 0.040 |
Why?
|
| Axons | 2 | 2012 | 33 | 0.040 |
Why?
|
| Solubility | 2 | 2015 | 38 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2020 | 11 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 622 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2020 | 29 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2002 | 129 | 0.040 |
Why?
|
| Mammals | 1 | 2020 | 13 | 0.040 |
Why?
|
| Collagen Type II | 2 | 2012 | 8 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2013 | 21 | 0.040 |
Why?
|
| Hypogastric Plexus | 1 | 2020 | 8 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 29 | 0.040 |
Why?
|
| Semen Analysis | 1 | 2020 | 2 | 0.040 |
Why?
|
| Hypogonadism | 1 | 2020 | 4 | 0.040 |
Why?
|
| Sperm Retrieval | 1 | 2020 | 3 | 0.040 |
Why?
|
| Azoospermia | 1 | 2020 | 7 | 0.040 |
Why?
|
| Crystallization | 2 | 2009 | 17 | 0.040 |
Why?
|
| Capsid | 1 | 2019 | 8 | 0.040 |
Why?
|
| Capsid Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
| Microvessels | 1 | 2020 | 28 | 0.040 |
Why?
|
| Aptamers, Nucleotide | 1 | 2019 | 10 | 0.040 |
Why?
|
| X Chromosome Inactivation | 2 | 2012 | 6 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2019 | 25 | 0.040 |
Why?
|
| Aromatase | 1 | 2019 | 12 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 767 | 0.040 |
Why?
|
| Pelvis | 1 | 2020 | 64 | 0.040 |
Why?
|
| Leukemic Infiltration | 1 | 2019 | 2 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Cues | 1 | 2019 | 67 | 0.040 |
Why?
|
| Methacrylates | 1 | 2019 | 3 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 28 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 34 | 0.040 |
Why?
|
| Random Allocation | 2 | 2010 | 229 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2019 | 162 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 48 | 0.040 |
Why?
|
| Nerve Net | 1 | 2020 | 125 | 0.040 |
Why?
|
| Chemokine CCL3 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2018 | 9 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2018 | 9 | 0.040 |
Why?
|
| Angiogenic Proteins | 1 | 2018 | 10 | 0.040 |
Why?
|
| Kupffer Cells | 1 | 2018 | 10 | 0.040 |
Why?
|
| Laminin | 1 | 2018 | 13 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 31 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2018 | 24 | 0.040 |
Why?
|
| Liposomes | 2 | 2009 | 30 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2018 | 99 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2018 | 80 | 0.040 |
Why?
|
| Strontium | 1 | 2017 | 5 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2017 | 9 | 0.030 |
Why?
|
| Hormones | 1 | 2017 | 20 | 0.030 |
Why?
|
| Particle Size | 2 | 2009 | 47 | 0.030 |
Why?
|
| Thermus thermophilus | 1 | 2017 | 2 | 0.030 |
Why?
|
| Tissue Expansion Devices | 1 | 2017 | 10 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2018 | 240 | 0.030 |
Why?
|
| Scrotum | 2 | 2008 | 7 | 0.030 |
Why?
|
| Lipids | 1 | 2018 | 229 | 0.030 |
Why?
|
| Microfibrils | 1 | 2016 | 3 | 0.030 |
Why?
|
| Capsules | 1 | 2016 | 14 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2012 | 862 | 0.030 |
Why?
|
| Sheep, Domestic | 1 | 2016 | 18 | 0.030 |
Why?
|
| Microtechnology | 1 | 2016 | 4 | 0.030 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2016 | 4 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 11 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2016 | 32 | 0.030 |
Why?
|
| Bone Density | 1 | 2017 | 203 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2008 | 169 | 0.030 |
Why?
|
| Myostatin | 1 | 2015 | 3 | 0.030 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2015 | 8 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2015 | 11 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2015 | 28 | 0.030 |
Why?
|
| Vimentin | 1 | 2015 | 9 | 0.030 |
Why?
|
| Optical Phenomena | 1 | 2015 | 5 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2015 | 33 | 0.030 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 37 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2005 | 72 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 76 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 49 | 0.030 |
Why?
|
| Polymethyl Methacrylate | 1 | 2015 | 12 | 0.030 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 9 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2014 | 5 | 0.030 |
Why?
|
| Echocardiography | 1 | 2015 | 182 | 0.030 |
Why?
|
| PAX7 Transcription Factor | 1 | 2014 | 8 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 241 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 55 | 0.030 |
Why?
|
| Adenosine | 1 | 2014 | 59 | 0.030 |
Why?
|
| Risk Factors | 1 | 2002 | 3974 | 0.030 |
Why?
|
| Tenascin | 1 | 2013 | 4 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2013 | 8 | 0.030 |
Why?
|
| Streptozocin | 1 | 2013 | 8 | 0.030 |
Why?
|
| Orthopedics | 1 | 2014 | 94 | 0.030 |
Why?
|
| Tendon Injuries | 1 | 2013 | 40 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 35 | 0.030 |
Why?
|
| Chorioallantoic Membrane | 1 | 2013 | 4 | 0.030 |
Why?
|
| Poloxamer | 1 | 2013 | 4 | 0.020 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2013 | 2 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 10 | 0.020 |
Why?
|
| Endocrine Cells | 1 | 2012 | 3 | 0.020 |
Why?
|
| Soft Tissue Injuries | 1 | 2013 | 20 | 0.020 |
Why?
|
| Patient Positioning | 1 | 2013 | 22 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 282 | 0.020 |
Why?
|
| Nanocapsules | 1 | 2012 | 4 | 0.020 |
Why?
|
| Hair Cells, Auditory | 1 | 2012 | 4 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 2013 | 14 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2012 | 16 | 0.020 |
Why?
|
| Teratoma | 1 | 2012 | 9 | 0.020 |
Why?
|
| S Phase | 1 | 2012 | 15 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2013 | 48 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 74 | 0.020 |
Why?
|
| Iodine | 1 | 2012 | 5 | 0.020 |
Why?
|
| Mitosis | 1 | 2012 | 24 | 0.020 |
Why?
|
| C-Peptide | 1 | 2012 | 30 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2012 | 6 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2012 | 16 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2012 | 24 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2012 | 19 | 0.020 |
Why?
|
| Peroneal Nerve | 1 | 2012 | 15 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2012 | 43 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 8 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2012 | 19 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2012 | 30 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2012 | 26 | 0.020 |
Why?
|
| Punctures | 1 | 2012 | 36 | 0.020 |
Why?
|
| Needles | 1 | 2012 | 31 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 6 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 85 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2013 | 48 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2012 | 15 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2012 | 3 | 0.020 |
Why?
|
| Aggrecans | 1 | 2012 | 3 | 0.020 |
Why?
|
| Anthraquinones | 1 | 2012 | 5 | 0.020 |
Why?
|
| Sepharose | 1 | 2012 | 6 | 0.020 |
Why?
|
| Enzymes, Immobilized | 1 | 2012 | 4 | 0.020 |
Why?
|
| PubMed | 1 | 2012 | 8 | 0.020 |
Why?
|
| Chondroitin Sulfates | 1 | 2012 | 21 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2012 | 16 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 135 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 51 | 0.020 |
Why?
|
| Amniocentesis | 1 | 2011 | 6 | 0.020 |
Why?
|
| Amines | 1 | 2012 | 22 | 0.020 |
Why?
|
| Pancreatic Diseases | 1 | 2012 | 19 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 35 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2011 | 4 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2012 | 16 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2012 | 24 | 0.020 |
Why?
|
| Ankle Joint | 1 | 2012 | 52 | 0.020 |
Why?
|
| Liver Failure | 1 | 2012 | 21 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 301 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 265 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 26 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2011 | 22 | 0.020 |
Why?
|
| Developmental Biology | 1 | 2011 | 6 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2013 | 431 | 0.020 |
Why?
|
| Trehalose | 1 | 2011 | 3 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2011 | 6 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 15 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2011 | 73 | 0.020 |
Why?
|
| Patient Selection | 1 | 2013 | 281 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2011 | 13 | 0.020 |
Why?
|
| Cell Communication | 1 | 2011 | 29 | 0.020 |
Why?
|
| Thrombin | 1 | 2010 | 16 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 494 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2010 | 45 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 2010 | 29 | 0.020 |
Why?
|
| Acetobacter | 1 | 2010 | 2 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2012 | 253 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 894 | 0.020 |
Why?
|
| Osteopontin | 1 | 2010 | 4 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 486 | 0.020 |
Why?
|
| Hernia | 1 | 2010 | 11 | 0.020 |
Why?
|
| Endotoxins | 1 | 2010 | 37 | 0.020 |
Why?
|
| PAX2 Transcription Factor | 1 | 2010 | 2 | 0.020 |
Why?
|
| Glycerol | 1 | 2010 | 6 | 0.020 |
Why?
|
| Rhabdomyolysis | 1 | 2010 | 6 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 15 | 0.020 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 23 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 198 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 35 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2009 | 17 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 16 | 0.020 |
Why?
|
| Octoxynol | 1 | 2009 | 6 | 0.020 |
Why?
|
| Stents | 1 | 2011 | 174 | 0.020 |
Why?
|
| Hematology | 1 | 2009 | 9 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 68 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2009 | 14 | 0.020 |
Why?
|
| Electroporation | 1 | 2009 | 14 | 0.020 |
Why?
|
| Gels | 1 | 2009 | 32 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2008 | 14 | 0.020 |
Why?
|
| Pancreas Transplantation | 1 | 2010 | 247 | 0.020 |
Why?
|
| Kidney Tubules, Distal | 1 | 2008 | 3 | 0.020 |
Why?
|
| Loop of Henle | 1 | 2008 | 4 | 0.020 |
Why?
|
| Peroxides | 1 | 2008 | 32 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Adenoviridae Infections | 1 | 2008 | 13 | 0.020 |
Why?
|
| Mucoproteins | 1 | 2008 | 13 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2008 | 29 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2009 | 94 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2008 | 14 | 0.020 |
Why?
|
| Mesoderm | 1 | 2008 | 13 | 0.020 |
Why?
|
| Microinjections | 1 | 2008 | 35 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2008 | 8 | 0.020 |
Why?
|
| Sural Nerve | 1 | 2008 | 27 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2008 | 39 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2008 | 51 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 2008 | 6 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 127 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2008 | 18 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2008 | 89 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 89 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2007 | 72 | 0.020 |
Why?
|
| Biopolymers | 1 | 2007 | 4 | 0.020 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2007 | 4 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2007 | 21 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 24 | 0.020 |
Why?
|
| Denervation | 1 | 2007 | 12 | 0.020 |
Why?
|
| Laryngeal Muscles | 1 | 2007 | 17 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2007 | 29 | 0.020 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2006 | 6 | 0.020 |
Why?
|
| Granuloma, Pyogenic | 1 | 2006 | 4 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 39 | 0.010 |
Why?
|
| Pyelonephritis | 1 | 2005 | 9 | 0.010 |
Why?
|
| Urinary Catheterization | 1 | 2005 | 16 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 35 | 0.010 |
Why?
|
| Genetic Enhancement | 1 | 2005 | 4 | 0.010 |
Why?
|
| Heart Failure | 1 | 2012 | 695 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 1 | 2005 | 36 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2005 | 27 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2005 | 13 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 292 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 247 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2009 | 636 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 2004 | 20 | 0.010 |
Why?
|
| Proline | 1 | 2004 | 11 | 0.010 |
Why?
|
| Guanine | 1 | 2004 | 15 | 0.010 |
Why?
|
| Thymine | 1 | 2004 | 6 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 39 | 0.010 |
Why?
|
| Cytosine | 1 | 2004 | 10 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 40 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 27 | 0.010 |
Why?
|
| Ploidies | 1 | 2003 | 7 | 0.010 |
Why?
|
| G1 Phase | 1 | 2003 | 11 | 0.010 |
Why?
|
| G2 Phase | 1 | 2003 | 17 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 352 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 193 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 258 | 0.010 |
Why?
|
| U937 Cells | 1 | 2002 | 8 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 2002 | 3 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2002 | 14 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 20 | 0.010 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2002 | 25 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 39 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 881 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 104 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2002 | 79 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2002 | 7 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2002 | 39 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 259 | 0.010 |
Why?
|